Free Trial

Vaxcyte (PCVX) News Today

$67.92
-0.78 (-1.14%)
(As of 05/29/2024 ET)
Monashee Investment Management LLC Invests $2.36 Million in Vaxcyte, Inc. (NASDAQ:PCVX)
Monashee Investment Management LLC purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 37,500 shares of the company's stock,
915,512 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Purchased by Norges Bank
Norges Bank purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 915,512 shares of the company's stock, valued at approximately $57,494
Westfield Capital Management Co. LP Buys 451,677 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
Westfield Capital Management Co. LP grew its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 45.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,455,593 shares of the company's stock after buying
Franklin Resources Inc. Raises Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Franklin Resources Inc. lifted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 12.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,076,920 shares of the company's stock after purchasing
Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells $599,920.00 in Stock
Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the firm's stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $74.99, for a total transaction of $599,920.00. Following the transaction, the chief financial officer now directly owns 95,679 shares in the company, valued at approximately $7,174,968.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Charles Schwab Investment Management Inc. Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)
Charles Schwab Investment Management Inc. grew its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 730,438 shares of the com
Natixis Advisors L.P. Invests $881,000 in Vaxcyte, Inc. (NASDAQ:PCVX)
Natixis Advisors L.P. purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 14,035 shares of the company's stock, valued at approximately $88
Vaxcyte (NASDAQ:PCVX) Trading 5.5% Higher
Vaxcyte (NASDAQ:PCVX) Trading 5.5% Higher
Nicholas Investment Partners LP Trims Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Nicholas Investment Partners LP lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 75.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 110,723 shares of the company's stock after selling 349,285 shares during t
Vaxcyte (NASDAQ:PCVX) Releases Earnings Results, Beats Estimates By $0.28 EPS
Vaxcyte (NASDAQ:PCVX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.85) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.13) by $0.28.
Vaxcyte (NASDAQ:PCVX) Stock Rating Reaffirmed by Cantor Fitzgerald
Cantor Fitzgerald reiterated an "overweight" rating on shares of Vaxcyte in a research report on Thursday.
Victory Capital Management Inc. Has $23.83 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Victory Capital Management Inc. reduced its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 12.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 379,407 shares of the company's stock after
abrdn plc Takes $12.20 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX)
abrdn plc acquired a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 194,232 shares of the company's stock, valued at approximately $12,198,000. abrdn plc owned
Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $928,800.00 in Stock
Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CEO Grant Pickering sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $61.92, for a total value of $928,800.00. Following the completion of the transaction, the chief executive officer now directly owns 477,847 shares in the company, valued at approximately $29,588,286.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Jennison Associates LLC
Jennison Associates LLC reduced its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 15.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,476,154 shares of the company's stock after selling 278,537 shares during the period. Jennison Associates LLC own
Andrew Guggenhime Sells 8,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock
Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the stock in a transaction that occurred on Thursday, April 18th. The stock was sold at an average price of $61.27, for a total transaction of $490,160.00. Following the completion of the sale, the chief financial officer now directly owns 95,679 shares of the company's stock, valued at $5,862,252.33. The transaction was disclosed in a filing with the SEC, which is available at this link.
Vaxcyte, Inc. (PCVX)
Mutual of America Capital Management LLC Acquires New Shares in Vaxcyte, Inc. (NASDAQ:PCVX)
Mutual of America Capital Management LLC acquired a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 48,330 shares of the company's stock, valued at a
Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Analysts
Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) has earned an average recommendation of "Buy" from the five brokerages that are covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have
Vaxcyte, Inc. (NASDAQ:PCVX) CEO Grant Pickering Sells 15,000 Shares
Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CEO Grant Pickering sold 15,000 shares of Vaxcyte stock in a transaction on Monday, March 25th. The stock was sold at an average price of $66.93, for a total value of $1,003,950.00. Following the sale, the chief executive officer now directly owns 477,847 shares of the company's stock, valued at approximately $31,982,299.71. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Vanguard Group Inc. Buys 47,872 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
Vanguard Group Inc. boosted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 0.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,284,246 shares of the company's stock
86,431 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Bought by Comerica Bank
Comerica Bank purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 86,431 shares of the company's stock, valued at approximately $4,4
PCVX Jul 2024 70.000 put
PCVX Apr 2024 80.000 put
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Citigroup Inc.
Citigroup Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 21.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 95,439 shares of the company's stock after purchasing an additional 16,816 shares during the quar
PCVX Apr 2024 100.000 call
Wellington Management Group LLP Acquires 167,501 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)
Wellington Management Group LLP grew its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 3.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,598,712 shares of the company's stock after buying an additional 167,5
Vaxcyte, Inc. (NASDAQ:PCVX) Sees Large Decline in Short Interest
Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) was the recipient of a large decrease in short interest in February. As of February 29th, there was short interest totalling 8,460,000 shares, a decrease of 20.6% from the February 14th total of 10,650,000 shares. Based on an average trading volume of 905,000 shares, the days-to-cover ratio is presently 9.3 days.
Adage Capital Partners GP L.L.C. Increases Position in Vaxcyte, Inc. (NASDAQ:PCVX)
Adage Capital Partners GP L.L.C. raised its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 119.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 132,088 shares of the company's stock after purc
Glenmede Trust Co. NA Acquires Shares of 14,938 Vaxcyte, Inc. (NASDAQ:PCVX)
Glenmede Trust Co. NA bought a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,938 shares of the company's stock, valued at approximately $762,000. Other la
Get Vaxcyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter.

Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

PCVX Media Mentions By Week

PCVX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PCVX
News Sentiment

1.10

0.80

Average
Medical
News Sentiment

PCVX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PCVX Articles
This Week

11

3

PCVX Articles
Average Week

Get Vaxcyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PCVX) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners